Cargando…
克唑替尼联合脑转移灶切除、全脑放疗治疗ROS1阳性伴有症状脑转移的肺腺癌
BACKGROUND AND OBJECTIVE: Lung cancer with brain metastasis had poor prognosis.Crizotinib had been confirmed to be used in ROS1 (C-ros oncogene 1 receptor tyrosine kinase) rearranged lung adenocarcinoma, but its efficacy in lung cancer with brain metastasis was poor due to the blood brain barrier.In...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972988/ https://www.ncbi.nlm.nih.gov/pubmed/27561802 http://dx.doi.org/10.3779/j.issn.1009-3419.2016.08.07 |